BioSyent Inc. BIOYF

Full chart Compare

Set alert

12.23 USD +0.02 (+0.16%)

Nov 2, 2026, 3:44 PM EST

12.23 Day range 12.30

7.63 52-week range 12.45

YTD: +28.47%
1 year: +55.99%

News

3 weeks ago defenseworld.net BioSyent (OTCMKTS:BIOYF) Stock Jumps 0.8% – Here’s Why Shares of BioSyent Inc. (OTCMKTS:BIOYF - Get Free Report) shot up 0.8% on Friday. The stock traded as high as $11.97 and last traded at $11.97. 880 shares were traded during trading, a decline of 64%…
3 months ago defenseworld.net BioSyent Inc. (OTCMKTS:BIOYF) Short Interest Down 47.3% in July BioSyent Inc. (OTCMKTS:BIOYF - Get Free Report) was the recipient of a significant decline in short interest during the month of July. As of July 15th, there was short interest totaling 4,285 shares,…
4 months ago globenewswire.com BioSyent to Present at Planet MicroCap Las Vegas MISSISSAUGA, Ontario, June 15, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Las Vegas investor conference…
5 months ago globenewswire.com BioSyent Announces Health Canada Approval of Thyconvi™ (levothyroxine oral solution) MISSISSAUGA, Ontario, May 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) announces that Health Canada has approved Thyconvi™ (levothyroxine sodium), the first…
5 months ago globenewswire.com BioSyent Declares Second Quarter 2026 Dividend MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend…
5 months ago globenewswire.com BioSyent Releases Financial Results for First Quarter 2026 MISSISSAUGA, Ontario, May 14, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the first quarter (Q1) ended March 31, 2026. Key highlights…
6 months ago globenewswire.com BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026 MISSISSAUGA, Ontario, May 07, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the first quarter ended March 31, 2026 on…
6 months ago globenewswire.com BioSyent to Present at 2026 Bloom Burton & Co. Healthcare Investor Conference MISSISSAUGA, Ontario, April 15, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX), a profitable growth-stage specialty healthcare products company, is pleased to announce that it…
7 months ago globenewswire.com BioSyent Announces Grant of Restricted Share Units MISSISSAUGA, Ontario, March 24, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent” or the “Company”, TSX Venture: RX) announces that its Board of Directors has approved a grant of 44,222 Restricted…
7 months ago seekingalpha.com BioSyent Inc. (RX:CA) Q4 2025 Earnings Call Prepared Remarks Transcript BioSyent Inc. (RX:CA) Q4 2025 Earnings Call Prepared Remarks Transcript
7 months ago globenewswire.com BioSyent Releases Financial Results for Fourth Quarter and Full Year 2025 MISSISSAUGA, Ontario, March 19, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the fourth quarter (Q4) and full year (FY) ended December…
7 months ago globenewswire.com BioSyent Schedules Fourth Quarter and Full Year 2025 Earnings Release for March 19, 2026 MISSISSAUGA, Ontario, March 12, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the fourth quarter and full year ended…
8 months ago globenewswire.com BioSyent Announces Closing of the Acquisition of Oral Science Inc. MISSISSAUGA, Ontario, March 02, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture (TSXV): RX) is pleased to announce that it has successfully closed the previously-announced acquisition…
8 months ago globenewswire.com BioSyent to Acquire Oral Science Inc. Accretive Transaction with Combined Companies' Pro-Forma Revenue in Excess of $70.00 Million and EBITDA(1) in Excess of $15.75 Million (TTM Sept 30, 2025)
9 months ago globenewswire.com BioSyent Declares First Quarter 2026 Dividend MISSISSAUGA, Ontario, Jan. 29, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend…
11 months ago seekingalpha.com BioSyent Inc. (RX:CA) Q3 2025 Earnings Call Prepared Remarks Transcript BioSyent Inc. ( RX:CA ) Q3 2025 Earnings Call November 19, 2025 7:00 PM EST Company Participants René Goehrum - Chairman, CEO & President Presentation René Goehrum Chairman, CEO & President Hello,…
11 months ago globenewswire.com BioSyent Releases Financial Results for Q3 and YTD 2025 MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q3) and nine months (YTD) ended…
11 months ago globenewswire.com BioSyent Declares Fourth Quarter 2025 Dividend MISSISSAUGA, Ontario, Nov. 20, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend…
1 year ago globenewswire.com BioSyent Releases Financial Results for Q2 and H1 2025 MISSISSAUGA, Ontario, Aug. 21, 2025 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q2) and six months (H1) ended June 30,…
7 years ago benzinga.com Stocks That Hit 52-Week Lows On Thursday